Ai Kozaki
Overview
Explore the profile of Ai Kozaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hiromatsu Y, Ishikawa E, Kozaki A, Takahashi Y, Tanabe M, Hayashi K, et al.
Lancet Reg Health West Pac
. 2025 Feb;
55:101464.
PMID: 39896230
Background: Teprotumumab significantly improved proptosis and diplopia in patients with active, moderate-to-severe thyroid eye disease (TED) in previous North American and European studies. This is the first evaluation of efficacy...
2.
Suzuki N, Yoshimura Noh J, Kozaki A, Watanabe N, Yoshihara A, Fukushita M, et al.
Endocr J
. 2024 Oct;
72(1):103-113.
PMID: 39443096
It has been reported that Graves' disease (GD) sometimes improves spontaneously during pregnancy, although exacerbation of GD during postpartum period or relapse of hyperthyroidism caused by GD might occur. This...
3.
Koshibu M, Watanabe N, Suzuki N, Takahashi Y, Onda H, Kozaki A, et al.
Intern Med
. 2024 Sep;
PMID: 39261069
A 37-year-old, never-smoker, pregnant woman diagnosed with Graves' disease who had stable thyroid eye disease (TED) before pregnancy presented with aggravated proptosis and eyelid swelling at 13 weeks of pregnancy....
4.
Tokuhisa T, Hayashi T, Omoto S, Kozaki A, Inoue T, Nakano T
Case Rep Ophthalmol
. 2024 Aug;
15(1):621-627.
PMID: 39144641
Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder that principally targets the central nervous system, specifically the spinal cord and optic nerves. NMOSD is often associated with thyroid...
5.
Kozaki A, Inoue R, Yaji N, Nishiyama K, Inoue T
Clin Ophthalmol
. 2024 Jul;
18:2147-2154.
PMID: 39070106
Purpose: To evaluate the efficacy of subcutaneous injection of triamcinolone acetonide (SCTA) in treating upper eyelid retraction and swelling in patients with thyroid eye disease (TED). Patients And Methods: This...
6.
Watanabe N, Kozaki A, Inoue K, Narimatsu H, Shinohara M, LoPresti M
J Endocr Soc
. 2023 Dec;
8(1):bvad148.
PMID: 38075564
Background: Although thyroid eye disease (TED) can impact social and psychological well-being, the epidemiological evidence of TED is lacking in Japan. Methods: Nationwide claims databases provided by JMDC Inc. and...
7.
Watanabe N, Yoshimura Noh J, Kozaki A, Yoshimura R, Yoshihara A, Suzuki N, et al.
Endocr J
. 2023 Sep;
70(11):1087-1096.
PMID: 37743517
Appropriate administration of anti-inflammatory and immunosuppressive treatment (AIIST) is important for patients with Graves' orbitopathy (GO). This study aimed to clarify the incidence and risk factors for GO treated with...
8.
Inoue S, Kawashima M, Arita R, Kozaki A, Tsubota K
J Clin Med
. 2020 Sep;
9(9).
PMID: 32878140
We prospectively evaluated the relationship between meibomian gland dysfunction (MGD) and Graves' ophthalmopathy (GO) in 19 patients (38 eyes) with subjective dry eye symptoms, compared to 14 age-matched normal participants...
9.
Kozaki A, Nakamura H, Inoue T
Int Med Case Rep J
. 2018 Dec;
11:325-331.
PMID: 30519121
Aim: To evaluate the efficacy of transcutaneous triamcinolone acetonide (TA) injection for the treatment of upper eyelid retraction and swelling in thyroid eye disease (TED) patients. Patients And Methods: This...
10.
Suzuki N, Yoshimura Noh J, Kameda T, Yoshihara A, Ohye H, Suzuki M, et al.
Clin Ophthalmol
. 2018 May;
12:739-746.
PMID: 29719374
Background: Euthyroid Graves' disease (EGD) is a rare condition defined as the presence of thyroid-associated ophthalmopathy (TAO) in patients with normal thyroid function. Due to the rarity of this disease,...